نتائج البحث 271-280 من 13305 لعملية البحث عن Cutaneous leishmaniasis
Johnson, M.D.. Dermatologist; Dermatopathologist. Rochester, MN. مناطق التركيز: Light therapy, Atopic dermatitis, Dermatitis, Cutaneous t-cell lymphoma, ...
N. Nora Bennani, M.D.. Internist; Oncologist; Hematologist. Rochester, MN. مناطق التركيز: CAR-T cell therapy, Cutaneous t- ...
Bachmann LH, et al. CDC clinical guidelines on the use of doxycycline postexposure prophylaxis for bacterial sexually transmitted infection prevention, United ...
The objective of this study is to compare the unipedal stance time with serum albumin, 5-meter walk test and KATZ questionnaire findings as frailty scores in ...
The purpose of this study is to evaluate immune profile of Acute Myeloid Leukemia (AML) patients receiving Venetoclax plus Azacitidine induction chemotherapy.
Rochester, Minn. The purpose of this study is to determine the impact of focused ultrasound (FUS) on the composition of the tumor extracellular microenvironment ...
Rochester, Minn. This clinical trial evaluates the use of microdialysis catheters during surgery to collect biomarkers, and studies the feasibility of ...
Treatment Of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA). Scottsdale/Phoenix, Ariz., Jacksonville, Fla., Rochester, Minn. The present study is ...
All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...
This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.